Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals.
about
The treatment of advanced renal cell cancer with high-dose oral thalidomideIn situ protein expression in tumour spheres: development of an immunostaining protocol for confocal microscopyThalidomide-induced limb defects: resolving a 50-year-old puzzle.Coenzyme Q and the regulation of intracellular steady-state levels of superoxide in HL-60 cells.Angiogenesis in hematologic malignancies and its clinical implications.Teratogenic effects of thalidomide: molecular mechanisms.Thalidomide: an old drug with new clinical applications.Thalidomide induces gamma-globin gene expression through increased reactive oxygen species-mediated p38 MAPK signaling and histone H4 acetylation in adult erythropoiesis.Drug bioactivation, covalent binding to target proteins and toxicity relevance.Lanreotide in the management of small bowel angioectasias: seven-year data from a tertiary centre.Oxidative stress as a mechanism of teratogenesis.Mechanism of teratogenesis: electron transfer, reactive oxygen species, and antioxidants.6"-Debromohamacanthin A, a bis (indole) alkaloid, inhibits angiogenesis by targeting the VEGFR2-mediated PI3K/AKT/mTOR signaling pathways.Large particle multiphoton flow cytometry to purify intact embryoid bodies exhibiting enhanced potential for cardiomyocyte differentiation.2',7'-Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: Forty years of application and controversy.Disruption of embryonic vascular development in predictive toxicology.Prenatal exposure to environmental factors and congenital limb defects.The antimalaria agent artemisinin exerts antiangiogenic effects in mouse embryonic stem cell-derived embryoid bodies.Coenzyme Q-dependent functions of plasma membrane in the aging process.DMSO mimics inhibitory effect of thalidomide on choriocapillary endothelial cell proliferation in culture.Nrf2-mediated resistance to oxidant-induced redox disruption in embryos.Antiproliferative effect of thalidomide alone and combined with carmustine against C6 rat glioma.The Dihydroxy Metabolite of the Teratogen Thalidomide Causes Oxidative DNA Damage.Enzymatic resolution and evaluation of enantiomers of cis-5'-hydroxythalidomide.The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity.Myricetin Inhibits Angiogenesis by Inducing Apoptosis and Suppressing PI3K/Akt/mTOR Signaling in Endothelial Cells.Overview of small bowel angioectasias: clinical presentation and treatment options.Impaired myocardial perfusion reserve in experimental hypercholesterolemia is independent of myocardial neovascularization.Combination of thalidomide and cisplatin in an head and neck squamous cell carcinomas model results in an enhanced antiangiogenic activity in vitro and in vivo.
P2860
Q28361231-DB5A9097-E387-4106-B8EF-20450D1A07C2Q30493990-1D0B7860-B4FD-4D8D-BBF3-CC78060D3352Q33348200-6E05262B-0E0E-49BD-BFFA-A855550278F8Q34551992-C51CE7F7-155A-4E48-9853-1B61D742DFDBQ34630626-42C5CFCF-04F3-4B8D-B443-8A58CD35DF55Q34660391-1FFDE7C4-2BF1-46CC-87EB-8FF39F126499Q34798767-C49B5AFC-23D4-452E-B5BD-ACA74508C53EQ36059602-CC59852A-B547-4F0F-9E31-31D193CA4481Q36061821-BD0AE708-3A66-455F-95C1-61F7D19F78F5Q36372377-B943135B-EF62-4874-959D-366DE937D90AQ36742133-27D7EB7B-8A35-4C10-B08A-5F1C7DC3EC27Q36742138-80A26E00-305C-4B56-BBD2-ED0B4C1B2E0EQ36994218-77FF171E-8FF7-4DFC-A617-7EB2FB3F38A4Q37102956-5D06F450-A374-4F3B-8A1E-E1C8DFABED18Q37724866-BBE08D39-E66C-42CD-B340-DF6AE5442A6EQ37978259-01A1C6B4-D41A-41F4-BA24-BA1472AF140FQ38987429-F2AD100B-DCC1-414F-A1D2-AADCF3D78927Q40616628-45916DA2-9CCE-4D8C-95FA-C4296BDDD4C2Q41826666-2C1389AB-673B-40B1-92DD-AE804B6CAFA5Q42064067-3BFCEC2B-92ED-405B-B145-7491F99F6C65Q42718951-982A3077-A7F7-4703-ADDB-9C28157D30B7Q44041377-45E0E946-70B7-44A6-BADF-86577FD6622EQ46330701-1E279928-01A8-47A4-8A6D-65E936E79DCDQ46637783-B112DD6F-25CF-46EC-B592-CD7B20BED217Q46699243-371154B4-D0EB-4A5C-91A4-969D0394100CQ47096744-69A089E2-C7E1-49DB-A0D8-76689A1B1219Q47906624-89BA1F2B-B58E-426E-9E20-B94436B9CE6DQ51925592-5D76AA10-BB6E-4CFA-9275-2BAC329E2591Q52831377-5D691CB7-B068-4F2F-A3B7-B6BB316227AC
P2860
Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Thalidomide inhibits angiogene ...... neration of hydroxyl radicals.
@ast
Thalidomide inhibits angiogene ...... neration of hydroxyl radicals.
@en
type
label
Thalidomide inhibits angiogene ...... neration of hydroxyl radicals.
@ast
Thalidomide inhibits angiogene ...... neration of hydroxyl radicals.
@en
prefLabel
Thalidomide inhibits angiogene ...... neration of hydroxyl radicals.
@ast
Thalidomide inhibits angiogene ...... neration of hydroxyl radicals.
@en
P2093
P2860
P1476
Thalidomide inhibits angiogene ...... neration of hydroxyl radicals.
@en
P2093
J Hescheler
M Wartenberg
P2860
P304
P356
10.1016/S0002-9440(10)64714-1
P407
P577
2000-01-01T00:00:00Z